Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 45

    1.

    Effect of Orchiectomy on Renal Function in Control and Diabetic Rats with Chronic Inhibition of Nitric Oxide.

    Anderson S, Chapman JG, Oyama TT, Komers R.

    Clin Exp Pharmacol Physiol. 2009 May 19. [Epub ahead of print]PMID: 19473197 [PubMed - as supplied by publisher]Related articles

    2.

    High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.

    Naito M, Shenoy A, Aoyama I, Koopmeiners JS, Komers R, Schnaper HW, Bomsztyk K.

    Am J Nephrol. 2009;30(2):99-111. Epub 2009 Feb 19.PMID: 19225232 [PubMed - indexed for MEDLINE]Related articles

    3.

    Inhibition of the renin-angiotensin system: is more better?

    Anderson S, Komers R.

    Kidney Int. 2009 Jan;75(1):12-4. Review.PMID: 19092813 [PubMed - indexed for MEDLINE]Related articles

    4.

    Aliskiren combined with losartan in diabetes and nephropathy.

    Anderson S, Komers R.

    N Engl J Med. 2008 Sep 4;359(10):1069; author reply 1069-70. No abstract available. PMID: 18777613 [PubMed - indexed for MEDLINE]Related articles

    5.

    Determination of caveolin-1 in renal caveolar and non-caveolar fractions in experimental type 1 diabetes.

    Demová H, Komers R.

    Physiol Res. 2009;58(4):563-8. Epub 2008 Jul 25.PMID: 18657009 [PubMed - in process]Related articlesFree article

    6.

    Renal activity of Akt kinase in obese Zucker rats.

    Zdychová J, Kazdová L, Pelikanová T, Lindsley JN, Anderson S, Komers R.

    Exp Biol Med (Maywood). 2008 Oct;233(10):1231-41. Epub 2008 Jul 18.PMID: 18641049 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Glomerular endothelial NOS (eNOS) expression in type 2 diabetic patients with nephropathy.

    Komers R, Anderson S.

    Nephrol Dial Transplant. 2008 Sep;23(9):3037; author reply 3037-8. Epub 2008 Jul 2. No abstract available. PMID: 18596128 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.

    Komers R, Schutzer W, Xue H, Oyama TT, Lindsley JN, Anderson S.

    Transl Res. 2007 Dec;150(6):343-9. Epub 2007 Aug 15.PMID: 18022596 [PubMed - indexed for MEDLINE]Related articles

    9.

    Renal activity of Akt kinase in experimental Type 1 diabetes.

    Zdychová J, Veselá J, Kazdová L, Komers R.

    Physiol Res. 2008;57(5):709-15. Epub 2007 Oct 11.PMID: 17949249 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Renal p38 MAP kinase activity in experimental diabetes.

    Komers R, Lindsley JN, Oyama TT, Cohen DM, Anderson S.

    Lab Invest. 2007 Jun;87(6):548-58. Epub 2007 Apr 2.PMID: 17401436 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats.

    Komers R, Lindsley JN, Oyama TT, Anderson S.

    Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):36-41.PMID: 17201733 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Effects of specific cycloxygenase-2 inhibition on the renal functions of ederly patients with renal function impairment]

    Horáková M, Schück O, Komers R, Teplan V, Charvát J, Kvapil M.

    Cas Lek Cesk. 2006;145(10):777-81. Czech. PMID: 17121069 [PubMed - indexed for MEDLINE]Related articles

    13.

    Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis.

    Lecian D, Demova H, Lodererova A, Zdychova J, Kluckova H, Teplan V, Voska L, Komers R.

    Kidney Blood Press Res. 2006;29(3):135-43. Epub 2006 Aug 7.PMID: 16899993 [PubMed - indexed for MEDLINE]Related articles

    14.

    Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney.

    Komers R, Schutzer WE, Reed JF, Lindsley JN, Oyama TT, Buck DC, Mader SL, Anderson S.

    Diabetes. 2006 Jun;55(6):1651-9.PMID: 16731827 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Gender hormones and the progression of experimental polycystic kidney disease.

    Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S.

    Kidney Int. 2005 Oct;68(4):1729-39.PMID: 16164649 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.

    Horackova M, Schück O, Komers R, Charvat J, Teplan V, Kvapil M.

    Int J Clin Pharmacol Ther. 2005 Sep;43(9):413-9.PMID: 16163893 [PubMed - indexed for MEDLINE]Related articles

    17.

    Renal cyclooxygenase-2 in obese Zucker (fatty) rats.

    Komers R, Zdychová J, Cahová M, Kazdová L, Lindsley JN, Anderson S.

    Kidney Int. 2005 Jun;67(6):2151-8.PMID: 15882258 [PubMed - indexed for MEDLINE]Related articles

    18.

    Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications.

    Zdychová J, Komers R.

    Physiol Res. 2005;54(1):1-16. Review.PMID: 15717836 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats.

    Komers R, Lindsley JN, Oyama TT, Anderson S.

    Nitric Oxide. 2004 Sep;11(2):147-55.PMID: 15491847 [PubMed - indexed for MEDLINE]Related articles

    20.

    Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.

    Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L.

    Kidney Blood Press Res. 2004;27(4):203-10. Epub 2004 Jul 20.PMID: 15273422 [PubMed - indexed for MEDLINE]Related articles

    21.

    Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.

    Komers R, Simkova R, Kazdova L, Ruzickova J, Pelikanova T.

    J Renin Angiotensin Aldosterone Syst. 2004 Mar;5(1):33-8.PMID: 15136972 [PubMed - indexed for MEDLINE]Related articles

    22.

    Paradoxes of nitric oxide in the diabetic kidney.

    Komers R, Anderson S.

    Am J Physiol Renal Physiol. 2003 Jun;284(6):F1121-37. Review.PMID: 12736164 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Cyclooxygenase-2 expression and function in renal pathophysiology.

    Komers R, Epstein M.

    J Hypertens Suppl. 2002 Sep;20(6):S11-5. Review.PMID: 12683422 [PubMed - indexed for MEDLINE]Related articles

    24.

    Endothelial-derived vasoactive mediators in polycystic kidney disease.

    Al-Nimri MA, Komers R, Oyama TT, Subramanya AR, Lindsley JN, Anderson S.

    Kidney Int. 2003 May;63(5):1776-84.PMID: 12675853 [PubMed - indexed for MEDLINE]Related articles

    25.

    Treatment of hypertension in diabetic patients with nephropathy.

    Komers R, Anderson S.

    Curr Diab Rep. 2001 Dec;1(3):251-60. Review.PMID: 12643207 [PubMed - indexed for MEDLINE]Related articles

    26.

    Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.

    Komers R, Tian W, Lindsley JN, Oyama TT, Cohen DM, Anderson S.

    J Lab Clin Med. 2002 Nov;140(5):351-7.PMID: 12434137 [PubMed - indexed for MEDLINE]Related articles

    27.

    Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.

    Komers R, Anderson S, Epstein M.

    Am J Kidney Dis. 2001 Dec;38(6):1145-57. Review.PMID: 11728945 [PubMed - indexed for MEDLINE]Related articles

    28.

    Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes.

    Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, Anderson S.

    J Clin Invest. 2001 Apr;107(7):889-98.PMID: 11285308 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.

    Komers R, Komersova K.

    Expert Opin Investig Drugs. 2000 Nov;9(11):2601-17. Review.PMID: 11060823 [PubMed - indexed for MEDLINE]Related articles

    31.

    Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.

    Komers R, Lindsley JN, Oyama TT, Allison KM, Anderson S.

    Am J Physiol Renal Physiol. 2000 Sep;279(3):F573-83.PMID: 10966937 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?

    Komers R, Anderson S.

    Curr Opin Nephrol Hypertens. 2000 Mar;9(2):173-9. Review.PMID: 10757223 [PubMed - indexed for MEDLINE]Related articles

    33.

    Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans.

    Komers R, Komersova K, Kazdova L, Ruzickova J, Pelikanova T.

    J Hypertens. 2000 Jan;18(1):51-9.PMID: 10678543 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats.

    Komers R, Oyama TT, Chapman JG, Allison KM, Anderson S.

    Hypertension. 2000 Feb;35(2):655-61.PMID: 10679513 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Effect of hyperinsulinaemia on renal function and nitrate/nitrite excretion in healthy subjects.

    Komers R, Pelikanová T, Kazdová L.

    Clin Exp Pharmacol Physiol. 1999 Apr;26(4):336-41.PMID: 10225145 [PubMed - indexed for MEDLINE]Related articles

    36.

    Thiazolidinediones--tools for the research of metabolic syndrome X.

    Komers R, Vrána A.

    Physiol Res. 1998;47(4):215-25. Review.PMID: 9803467 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Increased density of renal amylin binding sites in experimental hypertension.

    Wookey PJ, Cao Z, van Geenen RC, Voskuil M, Darby IA, Komers R, Cooper ME.

    Hypertension. 1997 Sep;30(3 Pt 1):455-60.PMID: 9314432 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Renal sodium handling in experimental diabetes: role of NO.

    Komers R, Cooper ME.

    Nephrol Dial Transplant. 1996 Nov;11(11):2170-7.PMID: 8941575 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    [Pathophysiologic mechanisms of early changes in renal hemodynamics in diabetes mellitus]

    Komers R.

    Cas Lek Cesk. 1996 Mar 6;135(5):135-9. Review. Czech. PMID: 8681353 [PubMed - indexed for MEDLINE]Related articles

    41.

    Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.

    Komers R, Cooper ME.

    Am J Physiol. 1995 Apr;268(4 Pt 2):F588-94.PMID: 7733315 [PubMed - indexed for MEDLINE]Related articles

    42.

    Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.

    Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K, Chou ST.

    Diabetes. 1994 Oct;43(10):1221-8.PMID: 7926292 [PubMed - indexed for MEDLINE]Related articles

    43.

    Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.

    Komers R, Allen TJ, Cooper ME.

    Diabetes. 1994 Oct;43(10):1190-7.PMID: 7926287 [PubMed - indexed for MEDLINE]Related articles

    44.

    [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy]

    Komers R, Malý J, Simková R.

    Cas Lek Cesk. 1993 Jun 14;132(12):359-64. Czech. PMID: 8343943 [PubMed - indexed for MEDLINE]Related articles

    45.

    The effects of dietary cholesterol on experimental diabetic nephropathy.

    Cooper ME, Vranes D, Vranes DA, Allen TJ, Panagiotopoulos S, Komers R, Jerums G.

    Diabetes Res. 1993;22(4):159-69.PMID: 8070237 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...